Core Wealth Advisors (Florida)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Core Wealth Advisors (Florida)'s MRNA Position: Q1 2022 in Review
Core Wealth Advisors (Florida) sold out of Moderna (MRNA) in Q1 2022, closing a stake of 19 shares — an estimated $5K sold.
Core Wealth Advisors (Florida) first reported a position in MRNA in Q1 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.
- Core Wealth Advisors (Florida) reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
- Core Wealth Advisors (Florida) sold 19 Moderna shares in Q1 2022, an estimated $5K.
- Core Wealth Advisors (Florida) first reported a position in Moderna in Q1 2021 and held it in 2 quarters.
- Core Wealth Advisors (Florida)'s Moderna position peaked at $5K in Q4 2021.
- 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.
Based on Core Wealth Advisors (Florida)'s 13F filing for Q1 2022, filed 16 May 2022.